Thiamine-responsive megaloblastic anaemia

Natl Med J India. 2023 Sep-Oct;36(5):314-315. doi: 10.25259/NMJI_20_21.

Abstract

We report a 26-year-old girl who was diagnosed with diabetes mellitus in her childhood and was treated with insulin. With a history of visual disturbances during her childhood and anaemia, which was partially evaluated; the possibility of syndromic diabetes was considered. Genetic analysis was done and revealed a mutation in the SLC19A2 gene, confirming the diagnosis of thiamine-responsive megaloblastic anaemia. She was supplemented with thiamine, which dramatically improved her haemoglobin levels and glucose control. However, her vision could not be salvaged as the rod-cone dystrophy is a permanent damage.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Megaloblastic* / diagnosis
  • Anemia, Megaloblastic* / drug therapy
  • Anemia, Megaloblastic* / genetics
  • Diabetes Mellitus
  • Female
  • Hearing Loss, Sensorineural
  • Humans
  • Membrane Transport Proteins / genetics
  • Mutation
  • Thiamine Deficiency* / congenital
  • Thiamine Deficiency* / diagnosis
  • Thiamine Deficiency* / drug therapy
  • Thiamine* / therapeutic use
  • Vitamin B Complex / therapeutic use

Substances

  • SLC19A2 protein, human

Supplementary concepts

  • Thiamine responsive megaloblastic anemia syndrome